Nanologica adderar ny produkt till portföljen av analytiska kolonner

Nanologica utökar portföljen av analytiska kolonner med kolonnen SVEA™ Amino som ett led i fortsatt utveckling för att förse marknaden med efterfrågade produkter. SVEA™ Amino är en kolonn tillverkad av Nanologicas silika, funktionaliserad med en aminopropylgrupp. Kolonnen kan användas inom reversed phase HPLC, normal phase HPLC och HILIC och rekommenderas exempelvis för separation av olika

Read more »

Nanologica Signs Agreement with Vicore Pharma Worth up to MSEK 8

Nanologica AB has within the project with Vicore Pharma been assigned to commence preparative work for the manufacturing of GMP classified material. The agreement is worth up to MSEK 8.   The VP02 project aims to deliver an API locally in the lung by formulating it using Nanologica’s technology platform for inhalation, NLAB Spiro™. The

Read more »

Nanologica is a public company listed for trade on Spotlight Stock Market. For information regarding financial reports, press releases, presentations and share holder information, please visit our investor relations section.

Presentation of Nanologica

Company presentation made by CEO Andreas Bhagwani on May 28, 2019.
For more videos about the Company as well as video presentations of interim reports, please refer to Investor Relations.